About
Full-Service CRO with expertise in Oncology, Radiopharma, Cell & Gene Therapy and Rare Diseases
Areas of Focus
Categories
Clinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchCg Medical WritingCg QualityClinical ResearchNorth & South Carolina
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
0
As Collaborator
6
Total Enrollment
378
By Phase
PHASE2: 1PHASE4: 2PHASE3: 2
By Status
RECRUITING: 3ACTIVE_NOT_RECRUITING: 2COMPLETED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06990529Collaborator
Long-term Safety and Efficacy of Leniolisib in PIDs With Immune Dysregulation
PHASE2Recruiting
12 participants
Started: Apr 29, 2025 · Completed: Apr 13, 2029
NCT06604442Collaborator
Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy
PHASE4Completed
55 participants
Started: Dec 4, 2024 · Completed: Aug 29, 2025
NCT06317805Collaborator
Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
PHASE4Recruiting
110 participants
Started: Dec 6, 2023 · Completed: Jun 30, 2027
NCT05693129Collaborator
Pediatric Patients Aged 1 to 6 Years With APDS
PHASE3Active, not recruiting
16 participants
Started: Aug 30, 2023 · Completed: Feb 28, 2026
NCT05438407Collaborator
Pediatric Patients Aged 4 to 11 Years With APDS
PHASE3Active, not recruiting
15 participants
Started: Feb 1, 2023 · Completed: Dec 30, 2025
Locations (1)
Headquarters
Raleigh, NC, United States
Map
Loading map...